These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 19553799

  • 21. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
    Ciulla TA, Rosenfeld PJ.
    Curr Opin Ophthalmol; 2009 May; 20(3):166-74. PubMed ID: 19381089
    [Abstract] [Full Text] [Related]

  • 22. Inhibiting angiogenesis in retinoblastoma.
    Apte RS, Harbour JW.
    Ophthalmic Res; 2007 May; 39(4):188-90. PubMed ID: 17556838
    [No Abstract] [Full Text] [Related]

  • 23. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M, Karl D, Georgopoulos M, Benesch T, Sacu S, Polak K, Zlabinger GJ, Schmidt-Erfurth U.
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [Abstract] [Full Text] [Related]

  • 24. Combination angiostatic therapies: current status.
    Peyman GA, Fiscella R, Conway M.
    Retina; 2009 Jun; 29(6 Suppl):S18-20. PubMed ID: 19553790
    [Abstract] [Full Text] [Related]

  • 25. Anti-macular degeneration agents.
    Rothen M, Jablon E, Monares G, Fontal MR, Alfaro DV.
    Ophthalmol Clin North Am; 2005 Dec; 18(4):561-7. PubMed ID: 16314219
    [Abstract] [Full Text] [Related]

  • 26. Vascular endothelial growth factors in retinal and choroidal neovascular diseases.
    Kinnunen K, Ylä-Herttuala S.
    Ann Med; 2012 Feb; 44(1):1-17. PubMed ID: 21284527
    [Abstract] [Full Text] [Related]

  • 27. Age-related macular degeneration and cardiovascular disease in the era of anti-vascular endothelial growth factor therapies.
    Wong TY.
    Am J Ophthalmol; 2009 Sep; 148(3):327-9. PubMed ID: 19703607
    [No Abstract] [Full Text] [Related]

  • 28. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
    Papadopoulou DN, Mendrinos E, Mangioris G, Donati G, Pournaras CJ.
    Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
    [Abstract] [Full Text] [Related]

  • 29. Rationale for combination therapies for choroidal neovascularization.
    Spaide RF.
    Am J Ophthalmol; 2006 Jan; 141(1):149-56. PubMed ID: 16386991
    [Abstract] [Full Text] [Related]

  • 30. The new face of age-related macular degeneration.
    Giuliari GP, Ciardella AP.
    Can J Ophthalmol; 2007 Aug; 42(4):629-30. PubMed ID: 17641716
    [No Abstract] [Full Text] [Related]

  • 31. The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration.
    Grisanti S, Tatar O.
    Prog Retin Eye Res; 2008 Jul; 27(4):372-90. PubMed ID: 18621565
    [Abstract] [Full Text] [Related]

  • 32. Effect of irradiation on neovascularization in rat skinfold chambers: implications for clinical trials of low-dose radiotherapy for wet-type age-related macular degeneration.
    Hori K, Saito S, Tamai M.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1564-71. PubMed ID: 15590188
    [Abstract] [Full Text] [Related]

  • 33. [Electroretinography in the diagnosis and monitoring of treatment for neovascular age-related macular degeneration: Communication 2].
    Zueva MV, Tsapenko IV, Riabina MV, Grinchenko MI, Neroeva NV.
    Vestn Oftalmol; 2009 Dec 01; 125(4):55-9. PubMed ID: 19824452
    [Abstract] [Full Text] [Related]

  • 34. A new treatment for ocular neovascularization.
    Ferris FL.
    N Engl J Med; 2004 Dec 30; 351(27):2863-5. PubMed ID: 15625339
    [No Abstract] [Full Text] [Related]

  • 35. Antiangiogenic approaches to age-related macular degeneration today.
    Bressler NM.
    Ophthalmology; 2009 Oct 30; 116(10 Suppl):S15-23. PubMed ID: 19800535
    [Abstract] [Full Text] [Related]

  • 36. Value-based medicine.
    Kymes SM, Vollman D, Frick KD.
    Ophthalmology; 2008 Nov 30; 115(11):2099; author reply 2100. PubMed ID: 19068385
    [No Abstract] [Full Text] [Related]

  • 37. Editorial: update on the modern management of wet age-related macular degeneration.
    Devenyi RG.
    Can J Ophthalmol; 2006 Apr 30; 41(2):133-8. PubMed ID: 16767199
    [No Abstract] [Full Text] [Related]

  • 38. Age-related macular degeneration: beyond anti-angiogenesis.
    Kent DL.
    Mol Vis; 2014 Jan 06; 20():46-55. PubMed ID: 24426775
    [Abstract] [Full Text] [Related]

  • 39. Current perspectives on established and novel therapies for pathological neovascularization in retinal disease.
    Campbell M, Doyle SL.
    Biochem Pharmacol; 2019 Jun 06; 164():321-325. PubMed ID: 31039332
    [Abstract] [Full Text] [Related]

  • 40. Overview of radiation trials for age-related macular degeneration.
    Kaiser PK.
    Retina; 2009 Jun 06; 29(6 Suppl):S34-5. PubMed ID: 19553797
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.